There are some topics that are so central to the experiences of both doctors and patients that they deserve an annual review.
For example, every September for as many years as I can remember, I have offered an update on all things anti-inflammatory in dry eye disease (DED). Believe it or not, if you add in the appearance of generics, insurance company shenanigans and the annual incredulous shock suffered by D.C. politicians when their collective backsides get nipped by the unforeseen consequences of their oddly named bills, I may never run out of stuff to say there.
Especially if Brent Saunders